Literature DB >> 22840522

Homeodomain-interacting protein kinase regulates Yorkie activity to promote tissue growth.

Joanna Chen1, Esther M Verheyen.   

Abstract

The Hippo (Hpo) tumor suppressor pathway regulates tissue size by inhibiting cell proliferation and promoting apoptosis. The core components of the pathway, Hpo, Salvador, Warts (Wts), and Mats, form a kinase cascade to inhibit the activity of Yorkie (Yki), the transcriptional effector of the pathway. Homeodomain-interacting protein kinases (Hipks) are a family of conserved serine/threonine kinases that function as regulators of various transcription factors to regulate developmental processes including proliferation, differentiation, and apoptosis. Hipk can induce tissue overgrowth in Drosophila. We demonstrate that Hipk is required to promote Yki activity. Hipk affects neither Yki stability nor its subcellular localization. Moreover, hipk knockdown suppresses the overgrowth and target gene expression caused by hyperactive Yki. Hipk phosphorylates Yki and in vivo analyses show that Hipk's regulation of Yki is kinase-dependent. To our knowledge, this is the first kinase identified to positively regulate Yki.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840522     DOI: 10.1016/j.cub.2012.06.074

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  26 in total

1.  Kicking it up a Notch for the best in show: Scalloped leads Yorkie into the haematopoietic arena.

Authors:  Gabriel B Ferguson; Julian A Martinez-Agosto
Journal:  Fly (Austin)       Date:  2014       Impact factor: 2.160

Review 2.  Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.

Authors:  Min Hwan Kim; Joon Kim
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

Review 3.  The Hippo signaling pathway in stem cell biology and cancer.

Authors:  Jung-Soon Mo; Hyun Woo Park; Kun-Liang Guan
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

Review 4.  The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.

Authors:  Randy Johnson; Georg Halder
Journal:  Nat Rev Drug Discov       Date:  2013-12-13       Impact factor: 84.694

5.  The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.

Authors:  Nina Reuven; Julia Adler; Ziv Porat; Tilman Polonio-Vallon; Thomas G Hofmann; Yosef Shaul
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

6.  Riquiqui and minibrain are regulators of the hippo pathway downstream of Dachsous.

Authors:  Joffrey L Degoutin; Claire C Milton; Eefang Yu; Marla Tipping; Floris Bosveld; Liu Yang; Yohanns Bellaiche; Alexey Veraksa; Kieran F Harvey
Journal:  Nat Cell Biol       Date:  2013-08-18       Impact factor: 28.824

7.  Rox8 promotes microRNA-dependent yki messenger RNA decay.

Authors:  Xiaowei Guo; Yihao Sun; Taha Azad; H J Janse van Rensburg; Jingjing Luo; Shuai Yang; Peng Liu; Zhongwei Lv; Meixiao Zhan; Ligong Lu; Yingqun Zhou; Xianjue Ma; Xiaoping Zhang; Xiaolong Yang; Lei Xue
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 8.  Integration of Hippo-YAP Signaling with Metabolism.

Authors:  Consuelo Ibar; Kenneth D Irvine
Journal:  Dev Cell       Date:  2020-07-20       Impact factor: 12.270

9.  The Hippo pathway controls border cell migration through distinct mechanisms in outer border cells and polar cells of the Drosophila ovary.

Authors:  Tzu-Huai Lin; Tsung-Han Yeh; Tsu-Wei Wang; Jenn-Yah Yu
Journal:  Genetics       Date:  2014-08-26       Impact factor: 4.562

Review 10.  The Hippo pathway and human cancer.

Authors:  Kieran F Harvey; Xiaomeng Zhang; David M Thomas
Journal:  Nat Rev Cancer       Date:  2013-03-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.